Alpha Cognition Inc. Retained Earnings
Alpha Cognition Inc. (ACOG) had Retained Earnings of -$112.37 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$112.37M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$103.58M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$97.11M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$90.10M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$112.37M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$103.58M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | -$97.11M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$90.10M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$88.78M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | -$78.29M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | -$76.44M 10-K · filed 2026-03-31 | -$76.29M 10-K · filed 2025-03-31 |
| 2024-09-30 | -$70.63M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$68.77M 10-Q · filed 2024-08-12 | |
| 2023-12-31 | -$61.65M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |